tion factor for erythroid cells (1). In addition, activin-A has a variety of important biological functions : it stimulates secretion of follicle-stimulating hormone from anterior pituitary cells (3), promotes survival of neuronal cells (4), and induces the mesoderm during xenopus development (5). With regard to vascular wall cells, it promotes SMC proliferation (6, 7) and inhibits EC growth (8) . We previously demonstrated that activin-A is expressed in the neointima of the WHHL rabbit (9). Activin-A was also identified in the media and neointima of the rat carotid artery, which was injured by balloon catheter withdrawal (7). Follistatin is a 35-kD, single chain glycoprotein , which binds to activin and blocks its action (10-12) . Follistatin is widely expressed in the body (13, 14) and proven to be bound to cell surface heparan sulfate proteoglycans (15) , thereby facilitating the access to activin . Hence, follistatin is considered to be an important modulator of activin's effect. We showed that follistatin is expressed in the neointima and media of the rat denuded carotid artery and produced by SMCs in vitro (16). Follistatin is also produced by growing endothelial cells (17, 18 Several studies have shown that activin-A promotes SMC growth (6, 7, 40) . Although its effect is slight by itself, activin-A markedly enhances the growth-promoting effect of EGF and heparin-binding EGF (7). Activin-A is also involved in the mitogenic effect of angiotensin II and thrombin, because anti-activin-A antibody blocks the stimulation of SMC growth by these two vasoactive substances (7). SMCs also produce follistatin (16, 40), whose production is augmented by PDGF (40).
In contrast to the effect on SMCs, activin-A inhibits the growth of ECs on which the type 2 activin receptors, ACTR2 and ACTR2B, are expressed (8). In addition, it was shown that ECs produce activin-A (8, 18), thereby inhibiting their growth in an autocrine manner. Production of activin-A by ECs is enhanced by TGF-R and inhibited by bFGF (8). Furthermore, ECs also produce follistatin, which is enhanced by bFGF (18). Its production is detected only in proliferating, not in resting, cells (17, 18) . Concerning this phenomenon, follistatin, when combined with bFGF, exhibits potent angiogenic activity, which was demonstrated in rabbit cornea (18). These findings indicate that the condition of activin/follistatin expression significantly affects the proliferative and angiogenic states of ECs. Exp Hematol, 20 : 1235 -1242 , 1992 
